Description
HUMA Peptide HEXA + CJC-1295 4 mg is an advanced dual-peptide research formulation combining GHRP-6 Hexarelin (HEXA) and CJC-1295, two extensively studied peptides recognized for their complementary roles in growth hormone signaling and endocrine research. By pairing a potent growth hormone secretagogue with a Growth Hormone Releasing Hormone (GHRH) analogue, this formulation provides researchers with an efficient platform for investigating peptide synergy, hormonal regulation, receptor interactions, and cellular signaling pathways.
Each pack contains 5 lyophilized vials, with 4 mg of the peptide blend per vial, offering a convenient multi-vial format for extended laboratory studies. Manufactured to rigorous research standards, HUMA Peptide HEXA + CJC-1295 delivers exceptional purity, stability, and consistency, making it a trusted choice for advanced peptide science and endocrine investigations.
Designed for precision and reliability, this premium research blend supports scientific exploration into growth hormone physiology, peptide pharmacology, metabolic biology, and regenerative signaling mechanisms in controlled laboratory environments.
Key Features
- Premium dual-peptide research blend
- Combines Hexarelin (HEXA) and CJC-1295 in one formulation
- Total peptide content: 4 mg per vial
- 5 lyophilized vials per pack
- High-purity research-grade formulation
- Commonly studied in growth hormone and endocrine pathway research
- Suitable for investigations involving peptide synergy, receptor signaling, and metabolic biology
- Manufactured under strict quality standards
- Intended exclusively for laboratory and scientific research applications
Contents
Active Ingredients: Hexarelin (HEXA) + CJC-1295 – 4 mg
Packaging: 5 Lyophilized Vials
Reviews
There are no reviews yet.